Sipuleucel-T: Autologous Cellular Immunotherapy for Men with Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate Cancer

Sipuleucel T is an autologous cellular immunotherapy designed to stimulate an immune response in men diagnosed with asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer. Sipuleucel T improves overall survival and provides an additional treatment op...

Descripción completa

Detalles Bibliográficos
Autor principal: Sims, Robert B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2011
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119403/
https://www.ncbi.nlm.nih.gov/pubmed/21716715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119403/
https://www.ncbi.nlm.nih.gov/pubmed/21716715

Ejemplares similares